Social network
Investors - Ensuring sustainable growth
Investors - Ensuring sustainable growth

Investors

Ensuring sustainable growth

Tools content (print, share, increase/decrease text size):

 

Key facts & figures

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare.

Solid financial performance in 2016

2016 Company Sales
€33,821m

-0.7% on a reported basis 
+1.2% at constant exchange rates (CER)

2016 Business EPS
€5.68

+0.7% on a reported basis 
+4.1% at CER

 

* Following the closing of the business swap with Boehringer Ingelheim, which consisted of an exchange of Sanofi’s animal health business and BI’s consumer healthcare business, sales are presented excluding Animal Health Business.
 
 

© Sanofi 2004-2017 - All rights reserved - Update: May 18, 2017

  • Site complies with W3C WCAG 2.0 (new window, in english)